HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of amibiasis with short-term secnidazole therapy].

Abstract
The authors have treated: a) 48 cases of E. histolytica histolytica intestinal amoebiasis by a single dose of 35 mg/kg of secnidazole with 98 p. 100 of parasitological success; b) 122 cases of E. histolytica minuta with several procedures: a unique dose of 25 mg/kg gives no success in 16.6 p. 100 of the cases, but the same single dose during three days gets only 2 p. 100 of failure; c) 22 cases of hepatic amoebiasis by a daily dose of 25 to 33 mg/kg during 5 days with success in every cases. Tolerance has been excellent. These short cures, facilitated by the long half-life of secnidazole are particularly easy to apply in developing countries.
AuthorsJ Cesari, M Condat, Y Gendron, P Saint-Andre, J Thomas, G Charmot
JournalMedecine tropicale : revue du Corps de sante colonial (Med Trop (Mars)) 1982 Sep-Oct Vol. 42 Issue 5 Pg. 527-30 ISSN: 0025-682X [Print] France
Vernacular TitleLe traitement de l'amibiase par le secnidazole en cure courte.
PMID7154901 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Metronidazole
  • secnidazole
Topics
  • Adult
  • Amebiasis (drug therapy)
  • Child
  • Drug Administration Schedule
  • Dysentery, Amebic (drug therapy)
  • Entamoebiasis (drug therapy)
  • Female
  • Humans
  • Liver Abscess, Amebic (drug therapy)
  • Male
  • Metronidazole (administration & dosage, adverse effects, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: